For the Inventor, By the Inventor

Enter assignee name

Progenika Biopharma S.a.

USPTO Granted Patents = 16

CIPO Patents = 1

EPO Patents = 11

Trademarks = 1

Forward Citations = 9

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

Laureano Simón Buela (7 out of 9 patents)

Jorge Ochoa (5 out of 5 patents)

Monica Lopez (5 out of 5 patents)

4. Diego Tejedor (5 out of 6 patents)

5. Antonio Martinez Martinez (5 out of 6 patents)

6. Antonio Martinez (5 out of 7 patents)

7. Antonio Martínez Martínez (5 out of 5 patents)

8. Diego Tejedor Hernández (4 out of 4 patents)

9. Daniel Nagore Casas (3 out of 4 patents)

10. Laureano Simon (2 out of 7 patents)

11. Alberto Monasterio Asteinza (2 out of 2 patents)

12. Nerea Torres Antúnez (2 out of 2 patents)

13. Araitz Molano (2 out of 2 patents)

14. Diego Tejedor Hernandez (2 out of 2 patents)

15. David Arteta (1 out of 3 patents)

16 patents: Sort by Forward Citations

1. 12422444 - Lateral flow immunoassays for the detection of antibodies against biological drugs (2025-09-23),

2. 12215376 - Mitochondrial nucleic acid depletion and detection (2025-02-04),

3. 10851413 - Consensus-based allele detection (2020-12-01),

4. 10830779 - Lateral flow immunoassays for the detection of antibodies against biological drugs (2020-11-10),

5. 10253366 - Discrimination of blood type variants (2019-04-09),

6. 10215762 - Method to optimize the treatment of patients with biological drugs (2019-02-26),

7. 9637788 - Discrimination of blood type variants (2017-05-02),

8. 9359643 - Discrimination of blood type variants (2016-06-07),

9. 9165108 - Probes and methods for determining the presence or absence of genetic segments (2015-10-20),

10. 9109257 - Prognostic method (2015-08-18),

11. 8712696 - Methods of prognosing a rheumatoid arthritis remission phenotype (2014-04-29),

12. 8669049 - Method and device for the detection of mutations in isolated gene sequences of the low-density lipoprotein receptor (LDL-r) which is associated with familial hypercholesterolemia (2014-03-11),

13. 8296073 - Diagnostic method (2012-10-23),

14. 8153363 - Methods and products for in vitro genotyping (2012-04-10),

15. 8124331 - In vitro method to detect bladder transitional cell carcinoma (2012-02-28),

Progenika Biopharma S.A. is a biotechnology company specializing in genetic testing and personalized medicine. They develop innovative diagnostic solutions for a wide range of diseases, including cancer, rare genetic disorders, and infectious diseases. With a focus on improving patient outcomes, Progenika Biopharma utilizes cutting-edge technologies and bioinformatics to provide accurate and comprehensive genetic testing. Through their research and collaborations, they aim to contribute to the advancement of precision medicine and improve healthcare globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

16 Patents

#1 in Derio

#126 in Spain

#36,651 in the World

Progenika Biopharma S.a.

Forward Citations = 9

50 inventors:

Laureano Simón Buela (7 out of 9 patents)

Jorge Ochoa (5 out of 5 patents)

Monica Lopez (5 out of 5 patents)

4. Diego Tejedor (5 out of 6 patents)

5. Antonio Martinez Martinez (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…